title: Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab.
authors.forename: A D
authors.initials: AD
authors.lastname: Kirk
authors.forename: D A
authors.initials: DA
authors.lastname: Hale
authors.forename: S J
authors.initials: SJ
authors.lastname: Swanson
authors.forename: R B
authors.initials: RB
authors.lastname: Mannon
mesh_terms: D000328:Adult; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000009:adverse effects*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D008212:Lymphocyte Depletion / Q000379:methods; D013967:Thyroiditis, Autoimmune / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000074323:Alemtuzumab